glp-1 medications and anesthesia Updated guidance for patients using GLP-1/GIP receptor agonists GLP-1 and Anesthesia: Considerations and
Description
completed a retrospective study on patients undergoing elective EGD, done in 2023
This made semaglutide the first GLP-1 RA approved specifically for kidney disease protection, paralleling the role of SGLT2 inhibitors in renal care
Several physiological and treatment-related factors can explain why tirzepatide may not produce the expected results
Research suggests that high-fibre breakfasts improve satiety and appetite regulation , making them a better choice for supporting natural GLP-1 levels and healthier eating patterns
